TLS data


Corporate Newsletter


Biocom Successfully Advocates for Digital Health Innovation during 2019 Fly-In

  • Fri Mar 29 16:55:00 GMT 2019
  • Washington DC
  • Author Laure Fabrega

On March 11-13, Biocom hosted our 2019 Connected Health Advocacy Fly-In, bringing small and large companies, research institutes and specialized firms to Washington, D.C. for two days of high-level meetings with senior officials in some of the most prestigious government institutions. Participants were given the opportunity to learn about our legislative and regulatory environments, while discussing their research, successes and challenges. Click here to view our press release.

Connected health harnesses the power of technology to improve health care delivery and outcomes, and lower health care costs. This year’s fly-In participants worked on a broad range of issues, from pain management and medication adherence to DNA databases and big data analysis, and together, advocated for regulatory, reimbursement, and data privacy and security policies that incentivize the development and use of connected health technologies. Increasing funding for the National Institutes of Health (NIH) and permanently repealing the medical device tax were also among the top priorities.

“California has long been the most innovative region in the world when it comes to developing new heath care products that can treat and cure some of the most dreadful diseases, improve health care quality and delivery, and create a more efficient, technology-¬enabled health care system at lower cost to public health,” said Joe Panetta, Biocom’s President & CEO. “Connected health is changing the American healthcare industry for the better, but work must be done to realize the full potential of these technologies. We must continue to work to revise outdated regulations that impede their development, expand reimbursement and ensure that they are appropriately integrated into clinical care.”

Biocom 2019 Fly-In participants had the opportunity to meet with officials at the Food and Drug Administration (FDA), including the Director of the Center for Devices and Radiologic Health (CDRH); the National Institutes of Health (NIH), including the Office of the Director and the National Institute of General Medical Sciences (NIGMS); and the Executive Director of Policy at the Office of the National Coordinator for Health Information Technology (ONC). In Congress, they met with the Senate Finance Committee, House Energy & Commerce Committee, Congressman Scott Peters (D-CA-52) and Congressman Mike Levin’s staff (D-CA-49).

This is Biocom’s fifth consecutive fly-in. Every year, our fly-ins focuses on a specific sector of our industry to allow for targeted and productive conversations. Past fly-ins included Digital Health, Precision Medicine, Oncology, and Regenerative Medicine. If you want to participate in future fly-ins or learn more about the program, please contact Biocom’s Director of Federal Policy and Government Affairs, Laure Fabrega at


Stay in the know with the Biocommunique

Sign up for Biocom's monthly newsletter to get all the latest life science news sent directly to your inbox.


Related Articles View All  
Sustainability is a hot topic amongst our members. Biocom is proud to connect them to our sustainable suppliers and help them with green business practices.  
50 bright young women were recognized and honored by committing to pursuing majors in STEM during STEM Signing Day.  
Come out and inspire future life science leaders at the largest science festival on the west coast!  
Takeaways from FDA Commissioner Dr. Scott Gottlieb's video conference interview and what you need to know about the government shutdown.